Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
393
datasets available to search
ShareScore release 0.9.0
Dataset results
393 results for “mRNA vaccine”
Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old
ClinicalTrials.gov study NCT05477186. IPD Sharing: YES. Countries: 3. Publications: 2.
Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine
ClinicalTrials.gov study NCT05315362. IPD Sharing: NO. Countries: 1. Publications: 1.
The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.
ClinicalTrials.gov study NCT05043311. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above
ClinicalTrials.gov study NCT04847102. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19
ClinicalTrials.gov study NCT04813796. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vac
ClinicalTrials.gov study NCT04765436. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster
ClinicalTrials.gov study NCT05897190. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine
ClinicalTrials.gov study NCT05636319. IPD Sharing: NO. Countries: 4. Publications: 1.
Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases
ClinicalTrials.gov study NCT05465863. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety Study About the mRNA Vaccines Against COVID-19 in Children (PEDIVACOV-HCSC)
ClinicalTrials.gov study NCT06646744. IPD Sharing: NO. Countries: 1. Publications: 7.
BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment
ClinicalTrials.gov study NCT04932863. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresect
ClinicalTrials.gov study NCT01066390. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population
ClinicalTrials.gov study NCT04649021. IPD Sharing: NO. Countries: 1. Publications: 1.
A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil
ClinicalTrials.gov study NCT05403307. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL
ClinicalTrials.gov study NCT04862806. IPD Sharing: NO. Countries: 1. Publications: 1.
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
ClinicalTrials.gov study NCT03897881. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644)
ClinicalTrials.gov study NCT05414786. IPD Sharing: YES. Countries: 2. Publications: 1.
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
ClinicalTrials.gov study NCT06141369. IPD Sharing: NO. Countries: 1. Publications: 27.
IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA)
ClinicalTrials.gov study NCT04832841. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clinical Trial of SARS-CoV-2 mRNA Vaccine in China
ClinicalTrials.gov study NCT05364047. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.